Destination Wealth Management Edwards Lifesciences Corp Transaction History

Destination Wealth Management

$3 Billion
Q2 2024

A detailed history of Destination Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Destination Wealth Management holds 6,819 shares of EW stock, worth $462,055. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,819

Previous 7,057 3.37%

Holding current value

$462,055

Previous $674,000 6.68%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$84.3 - $94.31 $20,063 - $22,445	-238 Reduced 3.37%	6,819 $629,000
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $29,088 - $38,319	-401 Reduced 5.38%	7,057 $674,000
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $103,549 - $130,481	-1,678 Reduced 18.37%	7,458 $568,000
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $6,997 - $9,431	-101 Reduced 1.09%	9,136 $632,000
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $34,192 - $39,618	-420 Reduced 4.35%	9,237 $871,000
Q1 2023 May 05, 2023	BUY	$74.26 - $84.51 $56,066 - $63,805	755 Added 8.48%	9,657 $798,000
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $3,551 - $4,546	52 Added 0.59%	8,902 $664,000
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $2,059 - $2,682	25 Added 0.28%	8,850 $731,000
Q2 2022 Jul 29, 2022	BUY	$86.5 - $128.27 $106,741 - $158,285	1,234 Added 16.26%	8,825 $839,000
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $16,721 - $21,047	-164 Reduced 2.11%	7,591 $894,000
Q4 2021 Feb 04, 2022	SELL	$106.37 - $130.68 $1,382 - $1,698	-13 Reduced 0.17%	7,755 $1.01 Million
Q3 2021 Oct 25, 2021	BUY	$102.91 - $122.75 $20,993 - $25,041	204 Added 2.7%	7,768 $879,000
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $4,527 - $5,657	-54 Reduced 0.71%	7,564 $783,000
Q1 2021 May 05, 2021	SELL	$78.68 - $90.67 $10,779 - $12,421	-137 Reduced 1.77%	7,618 $637,000
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $30,468 - $38,772	-425 Reduced 5.2%	7,755 $707,000
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $144,525 - $188,083	-2,151 Reduced 20.82%	8,180 $653,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $378,210 - $505,792	6,573 Added 174.91%	10,331 $714,000
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $4,350 - $6,723	-83 Reduced 2.16%	3,758 $709,000
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $6,811 - $7,798	95 Added 2.54%	3,841 $896,000
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $40,130 - $49,180	-652 Reduced 14.82%	3,746 $824,000
Q2 2019 Jul 19, 2019	BUY	$55.74 - $64.41 $48,995 - $56,616	879 Added 24.98%	4,398 $812,000
Q1 2019 May 01, 2019	BUY	$47.89 - $64.05 $2,107 - $2,818	44 Added 1.27%	3,519 $673,000
Q4 2018 Feb 05, 2019	BUY	$46.41 - $56.94 $90,592 - $111,146	1,952 Added 128.17%	3,475 $532,000
Q3 2018 Nov 07, 2018	BUY	$45.7 - $58.03 $66,676 - $84,665	1,459 Added 2279.69%	1,523 $265,000
Q2 2018 Jul 31, 2018	SELL	$42.45 - $51.3 $110,072 - $133,020	-2,593 Reduced 97.59%	64 $9,000
Q1 2018 Apr 05, 2018	BUY	$37.19 - $47.45 $98,813 - $126,074	2,657 New	2,657 $56,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Account

Destination Wealth Management Edwards Lifesciences Corp Transaction History